Comparative Efficacy of Vildagliptin and Sitagliptin in Japanese Patients with Type 2 Diabetes Mellitus

Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

(2010) Y. Iwamoto et al.   DIABETES OBESITY & METABOLISM

Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial

(2010) Y. Iwamoto et al.   DIABETES OBESITY & METABOLISM

Clinical evidence and mechanistic basis for vildagliptin's action when added to metformin

(2010) B. Ahrén et al.   DIABETES OBESITY & METABOLISM

DPP-4 inhibitors: What may be the clinical differentiators?

(2010) John Gerich   DIABETES RESEARCH AND CLINICAL PRACTICE

Global healthcare expenditure on diabetes for 2010 and 2030

(2010) Ping Zhang et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Relationship of baseline HbA1cand efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials

(2010) R. A. DeFronzo et al.   DIABETIC MEDICINE

Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus

(2010) Yasuhiko Iwamoto et al.   ENDOCRINE JOURNAL

Comparative Effectiveness Without Head-to-Head Trials

(2010) James E. Signorovitch et al.   PHARMACOECONOMICS

A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes

(2010) Walid K.H. Fakhoury et al.   PHARMACOLOGY

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

(2009) Masatoshi Kikuchi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Diabetes in Japan: a review of disease burden and approaches to treatment

(2009) Susan E. Neville et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Effects of Once-daily Sitagliptin on 24-h Glucose Control Following 4 Weeks of Treatment in Japanese Patients with Type 2 Diabetes Mellitus

(2009) K. Nonaka et al.   HORMONE AND METABOLIC RESEARCH

Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations

(2009) Raffaele Marfella et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

(2008) Kenji Nonaka et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Emerging dipeptidyl peptidase-4 inhibitors for the treatment of diabetes

(2008) Bo Ahrén   EXPERT OPINION ON EMERGING DRUGS

Use of Indirect and Mixed Treatment Comparisons for Technology Assessment

(2008) Alex Sutton et al.   PHARMACOECONOMICS